Immunohistochemistry and flow cytometry analyses following oHSV treatment have shown significant accumulation of CD8+ T cells in CNS tumors during preclinical studies10,11,24,25, and in blood and tumor tissue collected during trials in human patients15,26. This evidence concerns the gene CD8A and neoplasm.